“In-silico Design of a Core Scaffold Pyrazolone Fused Heterocyclic Analogues as Dual Inhibitors Targeting Breast Cancer”, AJPHS, vol. 11, no. 2, pp. 2468–2474, Jun. 2021, doi: 10.5530/qsrddd17.